Charles River Partners with Batavia
Dec 13 2012
Charles River is pleased to announce a new partnership, allowing us to offer our clients a seamless transition from cell line development through to cell banking, characterization and clinical-scale manufacturing of recombinant proteins, mAbs, gene therapies and virus products on a global level.
With GMP manufacturing facilities located in Leiden, Netherlands and additional facilities in Massachusetts, our new partner Batavia Bioservices provides clinical-scale manufacturing of proteins, antibodies, vaccines and vectors, and assists clients with cell line development, mammalian and microbial cell culture process development and purification process development.
This partnership will help advance our goal of making the development of drug products and vaccines as easy as possible for clients. Aided by the experience and scientific expertise of Batavia, Charles River is now able to provide clients with an even more complete solution for their early-stage drug product and vaccine development and manufacturing needs.
Related Information